USD 0.8 Billion
Human Microbiome Market Size, Share, Growth Analysis, By Product (Drugs, Probiotics), By Disease (Infectious Dieases, Gastrointestinal Diseases), By Type, By End User, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2299 |
Region:
Global |
Published Date: November, 2024
Pages:
201
|Tables:
90
|Figures:
74
Human Microbiome Market Insights
Human Microbiome Market size was valued at USD 1.01 Billion in 2023 and is poised to grow from USD 1.33 Billion in 2024 to USD 12.78 Billion by 2032, growing at a CAGR of 31.80% during the forecast period (2025-2032).
The human microbiome has recently become an area of interest due to its links to many respiratory and immune systems. The gut microbiome has been linked to a better immune system. Changes in the microbial populations of actinobacteria, firmicutes and bacteroidetes cause lung and respiratory problems. For example, the researchers said that it launched immune-enhancing microbiome therapies to help prevent and combat the new coronavirus (SARS-CoV-2), as well as water-stable tests to help identify patients. Thus, increasing research on microbiota are the major drivers for the growth of this market. The epidemic raises awareness of microbial chemistry and diagnosis. Thus, the market is expected to follow the same trend in the post-pandemic period.
Other major factors driving the growth of this market are increasing burden of lifestyle related diseases and increasing aging population. As according to International Diabetes Association 2021, 52.7 million people aged 20-79 years have diabetes, and the number is expected to reach 69 million in 2045.
The major drivers of the human microbiome market are the increasing application of microbiota in human health applications such as dietary supplementation and dermatology. In addition, technological advances in the microbial industry include next generation based sequencing and widespread use of microbial characterization that can enhance the microbial industry.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Drugs
Fastest Growth
Infectious Dieases
Growth Rate
31.80%
Global Human Microbiome Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Human Microbiome Market Segmental Analysis
Global Human Microbiome Market is segmented by Product, Disease, Type, End User, and region. Based on Product, the market is segmented into Drugs, Probiotics, Prebiotics, and Synbiotics. Based on Disease, the market is segmented into Infectious Dieases, Gastrointestinal Diseases, Endocrine and Metabolic Disorders, and Other Diseases. Based on Type, the market is segmented into Bacterial Consortia Transplantation (BCT)/ Fecal Microbiotia Transplantation (FMT), Live Biotherapeutic Product, and Others. Based on End User, the market is segmented into Hospitals and Clinics, Long-Term Care Facilities, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Disease Type
The infectious disease segment of the human microbiome market focuses on the prevention of viral infections by modifying the microorganisms. This segment focuses on microbial-based therapies, such as fecal bacteria microbial replacement therapy (FMT) and the use of genetically engineered probiotics, to restore a healthy microbial balance and prevent infectious diseases. Clostridium difficile which is often associated with drugs of antibiotic associated with increased antibiotic resistance. The search for the novel therapies is accelerating, and microbial based totally approaches are promising answers to manage the infection bacterial management. The infectious diseases phase dominated the market and generated sales of US$1.2 billion in 2022. The great expansion can be attributed to an increasing understanding of the complex relationship between the human microbiota and various infectious diseases.
The metabolic segment plays a key role in the human microbiome market by focusing on how the gut microbiome influences metabolic function and disease, especially conditions such as obesity, diabetes and metabolic syndrome. The research in this segment focuses on understanding the interactions between gut bacteria and metabolism. These bacteria are known to affect how the body metabolizes and stores energy, affecting things like insulin sensitivity, fat storage, glucose metabolism and others where companies are increasingly investing in personalized therapies, diagnostics and nutritional solutions to manage metabolic diseases.
Analysis by Application
The diagnostics segment plays an important role in the human microbiome market by enabling the detection and analysis of microbial structures in the human body. This segment focuses on developing advanced tools and technologies to detect microbial imbalances, which often linked to a variety of diseases such as gastrointestinal disorders, metabolism and even mental health information. There is also Nomics, which allows healthcare providers to assess a patient’s microbiome status and identify specific bacteria that may be contributing to disease. As diagnostic accuracy increases, microbiological diagnostics are increasingly used to monitor bacterial health and quickly identify imbalances and provide better treatment for preventive health care
The therapeutics segment achieved the highest industry share of 65.2% in 2022. This rapid expansion can be attributed to the impact of the human microbiome on both health and disease which is increasingly being acknowledged by more bacteria-based therapies were developed. The therapeutics segment leads innovation in the human microbiome market, focusing on the development of microbial-based therapies targeting a variety of diseases. The segment includes probiotics, prebiotics, fecal microbial transplantation (FMT), and microbial conjugate drugs. Medical applications aim to restore or maintain the microbial balance in the body, and address neurological conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), body dealing with metabolic disorders, depression etc. Medicine is increasingly being seen as an alternative to conventional drug treatments.
Global Human Microbiome Market By Application (%)
To get detailed analysis on other segments, Request For Free Sample Report
Human Microbiome Market Regional Insights
North America is expected to account for most of the global human microbiome market. The dominance of this region prominence from the growing social problems and the growing identity of the next generation. For instance, the American Cancer Society, estimates in 2022 that approximately 1,918,030 new cancers had been identified inside the United States in 2022. Additionally, there are 274,364 new cancers and they may be expected to attain new populations 400,564 by 2040. Thus, such increasing cancer burden is anticipated to drive the marketplace increase as gut microbiota plays a valid position in tumor remedy along with the improving patient accessibility the immune machine and lowering the aspect outcomes of chemotherapy.
Increasing disease burden in the region is also driving the growth of this market. For instance, the American Cancer Society, estimates in 2022 that about 1,918,030 new cancers had been identified in the United States in 2022. Thus, such increasing cancer burden is anticipated to force the marketplace growth as gut microbiota performs a legitimate role in tumor remedy consisting of the enhancing patient accessibility the immune gadget and reducing the facet results of chemotherapy.
Asia Pacific is expected to grow during the forecast period with increasing establishment of institutes working in microbiology e.g., in March 2020. Genomics and Integrative Biology Institute (IGIB) a CSIR institute, pioneer in public health genomics in India plans to enrol 20,000 Indians for whole genome sequencing over the next two years to create a large database. The information provided will be critical for building knowledge, baseline information and indigenous capacity in the emerging field of precision medicine.
Global Human Microbiome Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Human Microbiome Market Dynamics
Drivers
Increasing Prevalence of Chronic Diseases
- The increasing prevalence of chronic diseases such as gastrointestinal disorders, obesity, and diabetes is a key driver for the human microbiome market as more and more studies link gut microbiota to these conditions, generating demand for treatment and research based on the microbiome. This growing interest from the physicians and patients is spurring investment in research, innovation, and commercialization of the small-scale products.
Increasing Investment in Microbiology Research
- Public and private investments in microbiology research are driving rapid market growth. Governments, pharmaceutical companies, and biotech companies have focused on the small-scale interventions to address health issues. These investments are driving advances in microbial technology and increasing the number of clinical trials for microbial-targeted therapies.
Restraints
High R&D Costs
- The major restraint within the human microbiome marketplace is the high price of studies and improvement. The demanding situations of studying microbes and translating those findings into powerful remedies require tremendous sources. Clinical trials and regulatory approvals further contribute to increased costs over time, which can slow product innovation and market expansion.
Legal Challenges
- Regulatory barriers pose important additional constraints to the human microbial market. The difficulty of categorizing microbial-based and diagnostic therapies within existing regulatory frameworks makes approval difficult. This lack of clear guidelines may delay the introduction of new products, delaying and restricting potential growth in the market.
Request Free Customization of this report to help us to meet your business objectives.
Human Microbiome Market Competitive Landscape
A notable example of strategic engagement in the human microbiome market is the collaboration between Ceres Therapeutics and Nestle Health Science. This fellowship focuses on developing microbial therapies for a variety of health conditions, including gastrointestinal diseases. Nestlé’s investment and commercial potential, along with Ceres Therapeutics’ expertise in microbiology, will allow both companies to accelerate the development and commercialization of microbial-based therapies.
Top Player’s Company Profiles
- Seres Therapeutics, Inc. (US)
- Ferring Pharmaceuticals (Switzerland)
- Biomebank (Australia)
- Nestlé S.A. (Switzerland)
- Sanofi (France)
- Seed Health, Inc. (US)
- Enterome (France)
- Pendulum (US)
- Quantbiome, Inc. (Dba Ombre) (US)
- Vedanta Biosciences, Inc. (US)
- Maat Pharma SA (France)
- International Flavors & Fragrances, Inc. (US)
- Optibiotx Health Plc (UK)
- Synlogic, Inc. (US)
- Guangzhou Zhiyi Biotechnology Co., Ltd. (China)
- Aobiome (US)
- Siolta Therapeutics (US)
- Alveolus Bio, Inc. (US)
- Mrm Health NV (Belgium)
- Biome Inc (US)
- Sanzyme Biologics (India)
- Biomx (Israel)
- Nubiyota (US)
- Quorum Innovations (US)
Recent Developments
- September 2022: Seres Therapeutics Inc. completed its BLA application to the FDA for SER-109 for the prevention of recurrent C. difficile infection (rCDI). This is a relatively new therapy that promises to improve current care for rCDI.
- September 2022: Ferring Pharmaceuticals received a positive vote for RBX2660 from the FDA's Vaccine-Related Biological Products. Advisory Committee in an evaluation of a microbe-based survival biotherapy study for its ability to reduce recurrent C. difficile infection (CDI) after antibiotics.
- In July 2021, Ceres Therapeutics Inc. entered into an agreement with Nestle Health Science to commercialize SER-109, an investigational microbiome delivery therapy for the treatment of recurrent Clostridioides difficile infection (CDI) in the United States (U.S.)
Human Microbiome Key Market Trends
- Increasing Focus on Personalized Medicine: The shift closer to customized medicinal drug is a trend inside the human microbiome market. Researchers and pharmaceutical groups have an increasing number of targeted on tailoring organic treatments to character sufferers based totally on their specific microbial composition. This trend is leading to more targeted healing procedures and diagnostics, paving the manner for extra powerful agents to deal with the microbiota-associated sicknesses.
- Rising Emergence of Probiotics and Prebiotics: The increasing awareness of probiotics and prebiotics as part of maintaining a healthy microbiota is also changing the market. Demand for non-conventional products such as probiotics and prebiotics is growing as consumers become more health conscious. This trend is fueling the growth of functional foods and supplements designed to support gut health, thereby increasing the overall market.
Human Microbiome Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the human microbiome market is growing as researchers continue to explore the important role that microbes play in human health. This market is primarily driven by the increasing prevalence of chronic diseases such as gastroenteritis, diabetes, obesity, etc., which are associated with microbiome imbalances. Increasing investment in microbial research, especially in medicine and applied research is driving the market expansion. However, high R&D costs and regulatory challenges limit the growth potential. The market is also witnessing key trends, including a focus on generic medicine and the increasing popularity of probiotics and prebiotics.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 0.8 Billion |
| Market size value in 2031 | USD 9.7 Billion |
| Growth Rate | 31.80% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Human Microbiome Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Human Microbiome Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Human Microbiome Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Human Microbiome Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Human Microbiome Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Human Microbiome Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
